Engine Biosciences is a venture-backed technology company integrating experimental biology and data science to map and decipher complex biological networks for more effective and efficient drug discovery.
Engine’s technologies culminate from several years of research by our scientific founders and leaders who comprise faculty members of MIT, Harvard, Mayo Clinic, and UCSD, and our leadership team is applying our previous successful company building experiences to Engine to advance treatments to patients faster.
Applications of our broad platform include rational combination therapy development, drug repurposing, novel drug discovery, and precision medicine enablement, and we have published proof-of-concept results in leading peer-reviewed journals (Science, Cell, Nature Biotechnology, PNAS, and others). Engine is actively working in a range of indications through both internal work and partnerships with Fortune 500 companies and leading research institutions in USA and Asia.
We are based in San Francisco and in Singapore.